PDCD1 and neoplasm: Specifically, the PD-1 checkpoint inhibitor can effectively reduce the PD-1 expression of T cells, and influence the status of tumor cells, such as reducing the expression of PD-L1 on the tumor cells, facilitating the attack and elimination of tumor cells by T cells.